Skip to main content
Premium Trial:

Request an Annual Quote

Canadian Yeast Company, Lallemand, Expands Montreal R&D Facility With Eye to Genomics

NEW YORK, Aug. 13 (GenomeWeb News) –  Lallemand, a privately held Canadian company specializing in lactic acid bacteria and yeast, has announced that it is expanding its research facilities at Montreal’s Biotechnology Research Institute of the National Research Council of Canada.

The enlarged R&D team, led by Thomas Tompkins, will focus on biochemical and microbiological characterization of probiotic strains, their metabolic products, and mineral-enriched yeast.

The company said that its expanded research facilities would allow it to utilize genomic and proteomic technologies.